Posted by Hugo Ottolenghi
June 4th, 2010
The three little guys on Rice Krispies boxes are in trouble for claiming that their cereal supports the immune systems of children. The Federal Trade Commission announced on June 3 that Kellogg Co. had agreed to pull back on health claims for the puffy cereal. In a statement, commission chairman Jon Leibowitz said, “We expect [...]
Posted by Hugo Ottolenghi
May 26th, 2010
Nearly all of the herbal dietary supplements tested in a Congressional investigation contained trace amounts of lead and other contaminants, and some supplement sellers made illegal claims that their products can cure cancer and other diseases, investigators found. So begins an article in the New York Times on a Government Accounting Office report released May [...]
Posted by Hugo Ottolenghi
January 8th, 2010
Marketers of nutritional supplements often complain that they do not know what the FDA wants. Even after the agency sends a warning letter about misleading claims and advertising, its staff does not explain what would fall within the rules. That’s the reality; the FDA will tell you what’s wrong, not what’s right. Through warning letters, [...]
Posted by Hugo Ottolenghi
November 28th, 2009
David Frum could have lowered his rhetorical blood pressure in his CNN.com guest commentary on the evils of dietary supplement marketing by reading the FTC regulations that go into effect on Tuesday. His column then would have begun: The party is over Dec. 1.
Posted by Hugo Ottolenghi
November 16th, 2009
Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyperlinked line that warns consumers about the potential dangers of a drug.
Posted by Hugo Ottolenghi
November 13th, 2009
On Nov. 12, drugmakers and search-engine advertising agencies participated in about 30 presentations before the FDA. The hearing room was so crowded that most people seeking an audience seat were turned away. What did the company executives say?